Standout Papers

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias 2012 2026 2016 2021 512
  1. Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias (2012)
    Jörge E. Cortes, Hagop M. Kantarjian et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 11 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
2023 StandoutScience
10 intermediate papers

Works of Christopher D. Turner being referenced

Impact of baseline mutations on response to ponatinib and end of treatment mutation analysis in patients with chronic myeloid leukemia.
2013
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
2012 Standout

Author Peers

Author Last Decade Papers Cites
Christopher D. Turner 822 494 762 612 66 2.5k
Eric Sariban 1385 415 1142 1008 107 3.5k
Maya Koren‐Michowitz 594 236 837 726 76 2.8k
Giles H. Vince 639 369 712 140 108 3.3k
G Tobelem 371 398 1434 982 100 3.5k
John Camoriano 928 322 696 721 65 2.4k
Hans Kristian Ploos van Amstel 374 225 1565 566 64 3.7k
S P Balcerzak 406 1285 506 305 63 2.8k
Cornelius F. Waller 605 405 853 614 153 3.2k
Casilda Balmaceda 921 419 390 219 51 2.4k
James S. Nelson 1238 596 448 138 53 2.5k

All Works

Loading papers...

Rankless by CCL
2026